| Multiple Sclerosis Research Studies | Lifetime | 9 | CA 1 | 99.87 |
| Peripheral Neuropathies and Disorders | Lifetime | 22 | CA 1 | 99.65 |
| Polyomavirus and related diseases | Lifetime | 26 | CA 1 | 99.50 |
| Advanced MRI Techniques and Applications | Lifetime | 148 | CA 7 | 99.48 |
| Ultrasound and Hyperthermia Applications | Lifetime | 47 | CA 4 | 99.00 |
| RNA regulation and disease | Lifetime | 100 | CA 2 | 98.71 |
| Mitochondrial Function and Pathology | Lifetime | 328 | CA 14 | 98.85 |
| Systemic Lupus Erythematosus Research | Lifetime | 378 | CA 17 | 98.80 |
| Viral Infections and Immunology Research | Lifetime | 405 | CA 11 | 97.80 |
| Metabolism and Genetic Disorders | Lifetime | 853 | CA 32 | 97.65 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 459 | CA 29 | 98.13 |
| Epilepsy research and treatment | Lifetime | 735 | CA 37 | 97.15 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 864 | CA 41 | 96.88 |
| Genetic Neurodegenerative Diseases | Lifetime | 753 | CA 37 | 96.19 |
| Effects and risks of endocrine disrupting chemicals | Lifetime | 835 | CA 45 | 96.00 |
| Carcinogens and Genotoxicity Assessment | Lifetime | 962 | CA 31 | 95.81 |
| Medical Image Segmentation Techniques | Lifetime | 677 | CA 39 | 95.62 |
| Brain Tumor Detection and Classification | Lifetime | 518 | CA 14 | 90.53 |
| Ultrasound Imaging and Elastography | Lifetime | 684 | CA 45 | 92.11 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 966 | CA 45 | 91.52 |
| Infectious Encephalopathies and Encephalitis | Lifetime | 772 | CA 30 | 83.84 |
| Immunotoxicology and immune responses | Lifetime | 658 | CA 21 | 76.22 |
| Lymphadenopathy Diagnosis and Analysis | Lifetime | 307 | CA 9 | 54.47 |
| Multiple Sclerosis Research Studies | 2021-2025 | 26 | CA 1 | 99.44 |
| Polyomavirus and related diseases | 2021-2025 | 46 | CA 2 | 96.69 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 114 | CA 4 | 96.37 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 443 | CA 12 | 95.58 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 323 | CA 10 | 95.15 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 323 | CA 5 | 94.16 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 749 | CA 23 | 90.90 |
| RNA regulation and disease | 2021-2025 | 471 | CA 12 | 78.56 |
| Ultrasound and Hyperthermia Applications | 2021-2025 | 772 | CA 51 | 77.63 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 810 | CA 12 | 68.99 |
| Sphingolipid Metabolism and Signaling | 2021-2025 | 903 | CA 9 | 53.20 |
| Skin and Cellular Biology Research | 2021-2025 | 963 | CA 13 | 47.95 |
